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Objectives. We attempted to examine the interactions between
ultrasound and microbubbles.
Background. The interactions between microbubbles and ultra-
sound are poorly understood. We hypothesized that 1) ultrasound
destroys microbubbles, and 2) this destruction can be minimized
by limiting the exposure of microbubbles to ultrasound.
Methods. We performed in vitro and in vivo experiments in
which microbubbles were insonated at different frequencies,
transmission powers and pulsing intervals. Video intensity decay
was measured in vitro and confirmed by measurements of micro-
bubble size and concentrations. Peak video intensity and mean
microbubble myocardial transit rates were measured in vivo.
Results. Imaging at lower frequencies and higher transmission
powers resulted in more rapid video intensity decay (p 5 0.01),
and decreasing exposure of microbubbles to ultrasound mini-
mized their destruction in vitro. Although these effects were also
noted in vivo with venous injections of microbubbles, they were
not seen with aortic root or direct coronary artery injections.
Conclusions. Ultrasound results in microbubble destruction
that is more evident at lower frequencies and higher acoustic
powers. Reducing the exposure of microbubbles to ultrasound
minimizes their destruction. This effect is most marked in vivo
with venous rather than aortic or direct coronary injections of
microbubbles. These findings could lead to effective strategies for
myocardial perfusion imaging with venous injections of micro-
bubbles.
(J Am Coll Cardiol 1997;29:1081–8)
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Assessment of myocardial perfusion from a venous injection of
microbubbles is now feasible with the development of two
advances in ultrasound imaging. The first is intermittent imag-
ing (1). After venous injection of microbubbles, a transient but
significant increase in myocardial opacification occurs during
the initial exposure to ultrasound after its transmission is
suspended for a short period (1). The second advance is
harmonic imaging (2). Acoustic signals emanating from micro-
bubbles are much more likely to contain harmonics than are
those returning from tissue (2–4). Thus, transmitting ultra-
sound at one frequency but receiving a harmonic of that
frequency results in a decrease in clutter and an increase in the
signal to noise ratio during contrast echocardiography (2). The
combination of intermittent and harmonic imaging results in
excellent myocardial opacification during venous injection of
microbubbles (1). However, the mechanisms underlying the
success of intermittent harmonic imaging are poorly under-
stood. We hypothesized that 1) ultrasound destroys micro-
bubbles, and 2) decreasing the exposure of microbubbles to
ultrasound results in less bubble destruction and better myo-
cardial opacification. We tested these hypotheses using in vitro
and in vivo experiments.
Methods
In vitro experiments. Two ultrasound contrast agents, Al-
bunex and FS-069 (Molecular Biosystems Inc.), were used in
these experiments. These agents consist of air-filled and
perfluoropropane-filled albumin microspheres, respectively,
and have a mean size of 4.3 and 3.9 mm and a mean
concentration of 5 3 108zml21 and 8 3 108zml21, respectively
(5). Variable doses of these agents were mixed with 4 liters of
0.9% saline solution in a glass beaker. A magnetic stirrer
ensured constant mixing of the bubbles. The transducer was
held in a fixed position in the center of the beaker, 2 cm into
the solution, at a location where artifacts from the edges of the
beaker and the stirrer were minimal. The bubble solutions
were exposed to different frequencies, transmission powers
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and durations of exposure to ultrasound. Ultrasound-exposed
and nonexposed solutions were examined with an Electrozone
Celloscope (model 112 LTH, Particle Data) to determine the
size and concentration of microbubbles (6).
In vivo experiments. The study protocol was approved by
the Animal Research Committee at the University of Virginia
and conformed to the American Heart Association Guidelines
for Use of Animals in Research. Eight anesthetized open chest
adult mongrel dogs were studied. In seven dogs, Albunex was
injected through a 7F catheter placed in the aortic root with a
prototype low volume, high accuracy power injector (Medrad).
A dose of 1.5 to 5 ml of Albunex that resulted in optimal
myocardial opacification in individual dogs was chosen and
then held constant for the duration of the study. A 3-ml saline
flush was used and the total volume was injected over 3 s. In
the same dogs, 1 ml of FS-069 was also injected through a 7F
catheter in the right atrium followed by a 5-ml saline flush over
1.5 s.
In one dog, the proximal left anterior descending coronary
artery was ligated and perfused through a cannula with arterial
blood diverted from the right carotid artery. Flow to the
cannula was controlled with a peristaltic pump (model 2501,
Harvard Apparatus) and was measured with an extracorporeal
time of flight ultrasound flow probe (model SC, Transonics)
(7). Flow rates were adjusted from 15 to 60 mlzmin21 in
random order. Four injections of Albunex (1 ml over 1 s) were
performed at every flow rate to allow both continuous and
intermittent imaging at two mean frequencies (4 and 6 MHz).
Contrast echocardiography. For all in vitro and in vivo
experiments (except those involving direct coronary artery
injections of microbubbles), imaging was performed with the
use of a prototype phased-array system (Hewlett-Packard)
capable of continuous and intermittent imaging in both funda-
mental and harmonic modes. A different system (HDI-3000,
ATL-Interspec) was used for the experiment involving direct
coronary injections of microbubbles. Although this system is
also capable of both fundamental and intermittent imaging,
only the fundamental mode was used during both continuous
and intermittent imaging. For both systems, ultrasound is
transmitted and received along a specific line within a 90°
sector every 33 ms during continuous imaging. With intermit-
tent imaging, a sector is formed at discrete time intervals with
the use of either an internal timer or electrocardiographic
gating. In the latter instance, no ultrasound is transmitted
except during the 33 ms required to create the 90° sector at the
discrete time specified.
For most experiments, a transducer that transmits at a
mean frequency of 2 MHz was used. During fundamental
imaging, the same frequency is received; during harmonic
imaging, a multiple of this frequency (in this case 4 MHz) is
received. To study the effect of frequency on microbubble
destruction, transducers with mean transmission frequencies of
2.7, 5.5 and 7.5 MHz were also used for the in vitro experi-
ments. For the experiment involving direct intracoronary in-
jections of microbubbles, 4- and 6-MHz transducers were used.
All experiments were performed with the same logarithmic
compression to allow comparison of video intensity between
stages. The gain settings were optimized for each form of
imaging at the beginning of the experiment and then held
constant throughout. Because signals returning from tissue are
weaker during harmonic than during fundamental imaging, the
receive gain was increased during harmonic imaging to pro-
duce images obtained before injection of contrast medium that
had the same myocardial video intensity as those obtained
during fundamental imaging. Data were recorded on 1.25-cm
videotape by using an S-VHS recorder (Panasonic model
AG6200, Matsushita Electrical Co.) for later analysis.
Images were digitized as previously described (7). For the in
vitro experiments, a large region of interest ($3,000 pixels) was
defined around the focal point of the transducer, with care
taken to avoid the edges of the beaker. The background-
subtracted video intensity from this region was then plotted
against time and fitted to a sigmoid function:
y 5 A
exp@ 2 l~t 2 ts!#
1 1 exp@ 2 l~t 2 ts!#
1 C,
where y is video intensity; A is peak intensity, t is time, ts is the
time at which maximal slope occurs, l is the maximal slope
denoting the rate of video intensity decay and C is the
background video intensity (8). Although our data were back-
ground subtracted, the constant C was still used to minimize
any errors in calculation of background. All the decay curves
analyzed could be fitted well to the sigmoid function, with a
correlation coefficient of r . 0.90.
For the in vivo experiments, consecutive end-systolic
frames, which included the period from just before contrast
injection until 10 s thereafter, were selected and aligned by
using computer cross correlation (9). A large transmural
region of interest was defined over the anterior myocardium,
and the average video intensity within the region was deter-
mined for all end-systolic frames. The video intensity from
several frames before the appearance of contrast medium in
the myocardium was considered to represent background.
Time-intensity plots were generated from the background-
subtracted video intensity data and a gamma variate function,
y 5 Ate2}t, was applied to them, where A is a scaling factor,
t is time and } is proportional to the transit rate of the tracer
(9).
Statistical methods. Comparisons were performed by us-
ing a Student t test. The Bonferroni correction was imple-
mented for comparison of more than two sets of values.
Correlations were performed by using linear regression anal-
ysis. Differences were considered significant at p , 0.05
(two-sided).
Results
In vitro experiments. Effect of transmission frequency. The
5.5- and 7.5-MHz frequencies were from the same transducer
which was calibrated to produce similar pressure profiles
during transmission of both frequencies. The transmission
power for all transducers (including the 2.7-MHz transducer)
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was adjusted to be similar. At these settings, the peak negative
acoustic pressures were calculated to be 0.7 MPa for the 5.5-
and 7.5-MHz transducers and 1.0 MPa for the 2.7-MHz
transducer. The dose of Albunex was held constant for all
injections. Time-intensity curves obtained for Albunex during
continuous fundamental imaging with the three different trans-
ducer frequencies are depicted in Figure 1. The peak video
intensity was significantly higher (p , 0.01) at the 2.7-MHz
frequency than at the higher frequencies. It also decreased at
a dramatically higher rate (p 5 0.01) at this frequency (l 5
0.81) than at the higher frequencies, which showed similar
decay rates (l 5 0.09 and l 5 0.04, respectively, at 5.5 and
7.5 MHz, p 5 0.10).
Effect of harmonic versus fundamental imaging. Figure 2A
illustrates the effects of fundamental versus harmonic imaging
on video intensity decay of FS-069. Although the transmission
frequency (2 MHz) was identical for both forms of imaging, the
ultrasound energy delivered during harmonic imaging was
higher because the pulse length was almost double that used
for fundamental imaging. It can be seen that the peak video
intensity generated during harmonic imaging was significantly
greater than that generated during fundamental imaging (71 6
0.4 vs. 22 6 2.2 gray scale units, respectively, p 5 0.001). The
video intensity decay was also faster during harmonic than
during fundamental imaging (l 5 0.28 vs. 0.15, p , 0.01).
Effect of imaging rate. Figure 2B illustrates the effect of the
imaging rate on the decay of FS-069 with harmonic imaging,
which was performed with a 2-MHz transducer and a pulsing
interval of 250 ms. In the first curve an initial increase in the
video intensity occurs as the bubbles mix with saline solution,
which is followed by a gradual decay. The experiment was then
repeated with the same dose of microbubbles and imaging
variables. This time, ultrasound transmission was interrupted
for 30 s, 45 s after the introduction of microbubbles. It can be
seen from the second curve that when imaging was resumed,
the video intensity was unchanged. The results of a similar
experiment executed with Albunex are shown in Figure 3A.
Again, no change in the video intensity was seen after imaging
was restarted after two separate pauses. At the same system
settings and pulsing interval of 500 ms, the rate of video
intensity decay was greater for Albunex than for FS-069 (l 5
0.75 vs. 0.08, p , 0.01). These experiments were also per-
formed with FS-069 and Albunex in degassed saline solution
(Fig. 3B). The decays of the time-intensity plots from FS-069
were similar between the aerated and degassed solutions (l 5
0.08 and 0.11, respectively, p 5 NS). The decay occurred so
rapidly for Albunex in degassed saline solution that a time-
intensity curve could not be obtained.
To further examine the effect of imaging rate on video
intensity decay, time-intensity plots for the same dose of
FS-069 were generated at different pulsing intervals during
fundamental imaging with the use of a 2-MHz transducer. As
the pulsing interval was increased from 33 to 1,000 ms, greater
persistence of the contrast effect was seen (Fig. 4A). Figure 4B
illustrates the relation between the pulsing interval and video
intensity measured at 30 s from the curves shown in Figure 4A.
As the pulsing interval increased, the video intensity at 30 s
also increased until the pulsing interval reached 450 ms,
beyond which video intensity at 30 s reached a plateau.
Solutions of FS-069 were exposed to continuous and inter-
mittent fundamental imaging (an image formed every 500 ms
Figure 1. Time-intensity curves obtained for Albunex during continu-
ous fundamental imaging using transducers with three separate
frequencies—2.7 MHz (open circles), 5.5 MHz (solid squares) and
7.5 MHz (open triangles)—adjusted to generate similar transmission
powers. The dose of Albunex used was similar at the three frequencies.
Figure 2. A, Effect of fundamental (open circles) and harmonic (solid
circles) imaging on video intensity decay of FS-069 during continuous
transmission of ultrasound using the same transmission frequency
(2 MHz). B, Effect of no pause (solid circles) and a 30-s pause (open
circles, arrows) in ultrasound transmission on video intensity decay of
FS-069.
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in the latter case) for 30 s, and samples were then examined
with a particle counter to determine the concentration and size
of the microbubbles. The concentrations of microbubbles in
solutions subject to no ultrasound exposure, intermittent im-
aging and continuous imaging were 2.94 3 105zml21, 2.76 3
105zml21 and 1.71 3 105zml21, respectively. The average micro-
bubble size measured with the Electrozone Celloscope during
no ultrasound exposure and intermittent imaging at 500 ms
was 2.4 mm, whereas that during continuous imaging was
0.8 mm.
Effect of transmission power. The effect of transmission
power (using a 2-MHz transducer) on the microbubble back-
scatter of FS-069 during intermittent fundamental and har-
monic imaging is shown in Figure 5A. A setting of 50% of the
maximal transmission power resulted in a greater video inten-
sity decay than that seen at a setting of 25% of the maximal
power (l 5 0.7 vs. 0.18 for fundamental, and 1.31 vs. 0.67 for
harmonic imaging, respectively, p 5 0.01). Figure 5B illustrates
results of a similar experiment performed by using continuous
imaging with a 5.5-MHz transducer. Video intensity decay is
more rapid at the higher power settings. However, these
transducers are not comparable in total acoustic power.
In vivo experiments. Venous injection of contrast medium.
Venous injections of FS-069 resulted in much wider myocar-
dial time-intensity profiles than those seen with aortic root or
direct coronary injections of Albunex because of the wider
input function caused by bolus dispersion in the lungs in the
former (5). Intermittent imaging resulted in greater peak
background-subtracted myocardial video intensity than did
continuous imaging, for both fundamental (26 6 31 vs. 8 6
5 U, p , 0.001) and harmonic (56 6 22 vs. 11 6 9 U, p , 0.001)
imaging. The combination of intermittent and harmonic imag-
ing resulted in the greatest (p , 0.05) myocardial opacification
compared to all other forms of imaging.
Aortic root injection of contrast medium. The myocardial
peak video intensity for the seven dogs was 23 6 7 and 30 6
9 U for continuous and intermittent fundamental imaging (p 5
0.21), and 62 6 19 and 45 6 17 U for continuous and
intermittent harmonic imaging (p 5 0.07), respectively. Thus,
although it was higher during harmonic than during fundamen-
tal imaging, the rate of acquisition (intermittent vs. continu-
ous) did not influence the myocardial peak video intensity
measurement in either mode of imaging. The mean myocardial
microbubble transit rates for the seven dogs were also not
significantly different and measured, respectively, 1.11 6 0.23
and 1.06 6 0.2 s21 for continuous and intermittent fundamen-
tal imaging (p 5 0.74) and 1.26 6 0.25 and 1.33 6 0.42 s21 for
continuous and intermittent harmonic imaging (p 5 0.72).
Direct coronary artery injection of contrast medium. In the
single dog in which Albunex was injected directly into the
Figure 3. Time-intensity plots with intermittent harmonic imaging
(pulsing interval 250 ms) with (A) Albunex with two pauses (arrows) in
ultrasound transmission and (B), FS-069 microbubbles in aerated
(solid circles) and degassed (open circles) saline solution.
Figure 4. A, Effect of imaging rate on the persistence of FS-069. Open
squares 5 33 ms; solid squares 5 50 ms; open circles 5 83 ms; solid
circles 5 250 ms; open triangles 5 375 ms; solid triangles 5 500 ms;
solid diamonds 5 1,000 ms. B, Video intensity data from panel A after
30-s exposure to separate intermittent imaging sequences (33-ms to
600-ms pulse intervals) plotted against the pulsing interval.
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coronary artery, the imaging rate had no effect on the time-
intensity plots obtained at the same coronary flow rate. The
peak video intensity for the 4-MHz transducer was, respec-
tively, 30 6 6 and 33 6 6 U (p 5 0.20) for intermittent and
continuous imaging and 43 6 13 and 42 6 10 U (p 5 0.80) for
the 6-MHz transducer. Figure 6 shows the relation between
mean myocardial microbubble transit rates obtained from a
direct coronary injection of Albunex, and flow probe determi-
nations of coronary blood flow during continuous and inter-
mittent imaging. No significant differences were noted between
the correlations for the two transducers during continuous and
intermittent imaging.
Discussion
Why does intermittent imaging produce a greater contrast
effect? During the initial exposure to ultrasound after imaging
was suspended for a short period, Porter and Xie (1) observed
a transient but significant increase in myocardial opacification
with venous injection of microbubbles. They attributed this
finding to a transient increase in backscatter produced by a
direct effect of ultrasound and used the term “transient
response imaging” to define the phenomenon. There are three
possible ways in which ultrasound could increase backscatter:
1) acoustic cavitation, in which new gas bubbles are forced out
of solution by the acoustic power of ultrasound; 2) a transient
enlargement of bubbles already present in the field on expo-
sure to ultrasound; and 3) an increase in bubble size caused by
back-diffusion of gases during the suspension of ultrasound
transmission.
The pressure required for acoustic cavitation in water can
be achieved by instruments in clinical use (10) and has been
demonstrated experimentally (11). It has also been shown that
bubbles can enlarge when exposed to an ultrasound field (12).
However, both effects are transient, lasting for only millisec-
onds (11). Growth in bubble size by back-diffusion of gases that
are at higher partial pressures in the medium than in the
bubbles has also been reported (13).
In our in vitro experiments, microbubbles were suspended
in a glass beaker with a magnetic stirrer so that they were
constantly entering and leaving the ultrasound beam. There-
fore, the video intensity at any point in time within the region
Figure 5. Effect of transmission power on the rate of video intensity
decay of FS-069 during fundamental imaging with 2.0-MHz (A) and
5.5-MHz (B) transducers. The former is during the intermittent and
the latter during the continuous mode. PP 5 peak pressure as a
function of transmission power. A, Solid and open circles 5 harmonic
PP of 650 and 463 kPa, respectively; solid and open squares 5
fundamental PP of 650 and 463 kPa, respectively. B, Solid and open
circles 5 PP of 75 and 300 W/cm2, respectively.
Figure 6. Plots of mean myocardial transit rate of microbubbles versus
coronary blood flow when fundamental imaging was performed with a
4-MHz (A) and a 6-MHz (B) transducer and Albunex was injected
directly into the coronary artery as an instantaneous bolus in a single
dog. The relation during continuous imaging is depicted as a solid line,
that during intermittent imaging as a dashed line.
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of interest represented the average video intensity in the entire
beaker and not just that within the ultrasound beam itself. In
this system, with no bubble flux, an increase in video intensity
was not observed after a pause in the transmission of ultra-
sound. The absence of any increase in the video intensity after
resumption of ultrasound transmission suggests that either the
three effects just described were not operational or that they
were too brief to cause any change in measured backscatter.
Even though transient cavitation is an unlikely mechanism
for the increased video intensity, it is possible that microcavi-
tation undetectable by our ultrasound systems contributes to
bubble destruction. Explosion of small microbubbles caused by
cavitation can conceivably destroy neighboring bubbles. Be-
cause microcavitation requires that gas be present in the
medium, we compared the video intensity decay rates of
microbubbles by using both aerated and degassed saline solu-
tion, and we found similar decay in both solutions. Therefore,
our results do not support the role of microcavitation for either
a transient increase in video intensity or for microbubble
destruction.
Our experiments provide both direct and indirect evidence
that ultrasound destroys microbubbles. The decay in video
intensity during ultrasound exposure, and the lack of this decay
with cessation of ultrasound transmission, provides indirect
evidence for this effect. Direct evidence of microbubble de-
struction comes from our measurements of microbubble size
and concentration before and after exposure to ultrasound.
Like others (7), we found that a sigmoid function best de-
scribes microbubble decay in solutions. Each curve is charac-
terized by an initial flat slope, which indicates that bubbles
closest to the transducer shield other bubbles from destruction,
since a concentrated bubble solution impedes the transmission
of ultrasound (13). As bubbles are destroyed, there is less
shielding, resulting in accelerated bubble destruction, which is
represented by the steep portion of the curve. The second
flattening of the curve is probably caused by the smaller
bubbles that are not destroyed or are created by the disinte-
gration of larger bubbles during ultrasound exposure.
In comparison with the in vitro observations, and similar to
Porter and Xie (1), we noted a dramatic but transient increase
in myocardial opacification after a pause of ultrasound trans-
mission during venous injection of microbubbles in dogs. The
difference between the in vitro and in vivo settings is that the
former represents a closed system, whereas the latter does not.
During the pause in ultrasound transmission, microbubbles in
the pulmonary circulation and left ventricular cavity that have
not been destroyed by ultrasound enter the coronary microcir-
culation. Interrupting ultrasound transmission results in
greater opacification by permitting the myocardial sample
being insonated to become replenished with these bubbles.
The elevation (thickness) of an ultrasound beam is
;0.5 cm. Microbubbles that exhibit a microvascular rheology
similar to that of red blood cells (7,15) have a mean velocity in
tissue of ;0.1 to ;0.2 cmzs21 at baseline. It will therefore take
3 to 5 s in the absence of ultrasound to completely fill the
elevation with new microbubbles. Thus, the best contrast effect
will be noted with a long pulsing interval. If imaging is
performed at a rate faster than the rate of microbubble
replenishment, microbubbles will be continuously destroyed
and no tissue perfusion will be seen. However, if the velocity of
microbubbles is greater than the pulsing interval, contrast
effect will be noted. This is the reason why larger vessels (such
as septal perforators, where the velocity of red blood cells is an
order of magnitude higher than that in the microvessels) are
seen even during continuous harmonic imaging, whereas no
perfusion is noted in the microvasculature (16).
Why, then, is this effect of intermittent imaging not noted
during aortic root or direct coronary injections of micro-
bubbles? Myocardial concentrations of microbubbles are much
higher after aortic or coronary than after venous injections, so
that destruction of a portion of the microbubbles may not
result in an appreciable change in video intensity. Further-
more, the use of higher frequencies results in less bubble
destruction even during continuous imaging. These results
have important bearing on our previous data (7,17) showing a
close correlation between mean microbubble transit rate and
myocardial blood flow with direct coronary injections of mi-
crobubbles. Therefore, as long as microbubbles are not de-
stroyed in appreciable quantities, the use of tracer kinetic
principles remains valid for the measurement of mean transit
rates through tissues during arterial injections of microbubbles.
Why does ultrasound destroy microbubbles? Although our
results indicate that ultrasound destroys microbubbles, the
exact mechanism causing this effect is not addressed by our
experiments. It is possible that either the induction of nonlin-
ear oscillations or a direct physical impact of ultrasound, or a
combination of both, results in bubble destruction. Because of
their compressibility, bubbles in an ultrasound field undergo
radial oscillations that are maximal at the resonating frequency
(2,3,18). The bubbles that cause myocardial opacification from
a venous injection have a diameter of ;4 to 6 mm. The
resonant frequencies of bubbles this size are, by serendipity, in
the range of frequencies used clinically in adults. Smaller
bubbles have resonant frequencies that are above the clinically
useful range in most adults, whereas larger bubbles cannot
cross the pulmonary microcirculation.
On the basis of our results, it is attractive to postulate that
nonlinear oscillations produced at the resonant frequency
cause microbubble destruction. The higher rate of destruction
at the 2.7-MHz frequency than at the higher frequencies (Fig
1A) would support this contention as the resonant frequency of
Albunex is in this range (19). Given its similar size and shell
structure, FS-069 would also be expected to have the same
resonant frequency. Because harmonic signals can emanate
from microbubbles during resonance (2,3,13), it is possible that
the bubbles oscillate nonlinearly, release harmonic signals
(7,15) and are then destroyed. The success of intermittent
harmonic imaging could almost entirely be attributed to this
cascade of events.
The acoustic power to which a microbubble is exposed,
however, is related not only directly to the transmission power
but also inversely to the square root of the transmission
1086 WEI ET AL. JACC Vol. 29, No. 5
INTERACTIONS BETWEEN MICROBUBBLES AND ULTRASOUND April 1997:1081–8
frequency. Thus, although we could keep the transmission
power the same during all frequencies, we could not control for
the total acoustic power. As stated, the peak negative acoustic
pressure is greater for a lower frequency transducer, and thus
the total acoustic power is higher. We also noted greater
microbubble decay during harmonic than during fundamental
imaging when using a 2-MHz transducer. If resonance were the
primary cause for bubble destruction, this phenomenon would
not occur because the transmission frequency used for both
forms of imaging is the same. We also noted that the increase
in myocardial opacification was greater when ultrasound was
paused during harmonic compared with fundamental imaging.
In the instrument we used, the ultrasound energy delivered is
higher per image line during harmonic than during fundamen-
tal imaging because the ultrasound pulse is almost twice as
long during the former, which can explain these observations.
Increase in acoustic power may explain bubble destruction,
a view that is also supported by the finding that increasing the
transmission power enhances bubble destruction at any fre-
quency. Similar results have been previously reported (20).
Even though others (8,21) have shown that the ambient
pressure also affects bubble integrity, the peak negative pres-
sure of ultrasound far exceeds peak left ventricular systolic
pressures. The peak pressures around the focal point of the
2-MHz transducer used in our study was 463 kPa (3.5 3 103
mm Hg) at a power setting of 25% of maximal and 650 kPa
(4.9 3 103 mm Hg) at a setting of 50% of maximal.
On the basis of the preceding discussion, it is conceivable
that ultrasound can directly cause bubble destruction without
first causing resonance. Why, then, is myocardial opacification
better at the resonant frequency? The acoustic emission
caused by bubble destruction contains many frequencies, in-
cluding the harmonic frequency. Thus, it is not necessary to
invoke nonlinear oscillations as the sole mechanism for in-
creased opacification during harmonic imaging. Irrespective of
the mechanism underlying the production of harmonic signals
from microbubbles, because tissue has few harmonic proper-
ties (22), the signal to noise ratio after microbubble injection is
significantly greater during harmonic than during fundamental
imaging (where the signal includes backscatter from both
bubbles and tissue), resulting in better myocardial opacifica-
tion. Therefore, greater destruction of microbubbles can ex-
plain both the faster rate of video intensity decay and the
higher video intensity during intermittent imaging when the
harmonic rather than the fundamental mode is used.
Unique properties of different microbubbles. Our results
pertain to only two commercially produced microbubbles. The
interaction with ultrasound may be different for other agents.
Even in our experiments, the rate of video intensity decay of
FS-069 was noted to be slower than that of Albunex, although
both microbubbles have the same shell (5). It is possible that
even if the shell of the FS-069 microbubble were destroyed by
ultrasound as easily as that of Albunex, the low solubility of
perfluoropropane could allow the gases to remain in suspen-
sion longer than the highly soluble air present in Albunex.
Products similar to Albunex, but with a thicker shell, may not
be physically destroyed by ultrasound, although ultrasound at
high acoustic pressure might force air out of the shells,
producing harmonic signals before they dissolve in blood.
Having lost their gas content, these bubbles may not produce
enough signals on subsequent ultrasound exposure.
Depending on their shell composition or method of prep-
aration, some microbubbles may not be destroyed by ultra-
sound. In light of the preceding discussion, these bubbles
would be unlikely to exhibit increased signals during harmonic
imaging. Other microbubbles, because their small size makes
them inefficient scatterers of ultrasound, may depend entirely
on bubble destruction for their acoustic effects (23). Several of
the microbubbles studied by us (24–26) seem to have proper-
ties that are qualitatively similar to those of FS-069 described
here.
Bubble destruction by ultrasound may have other interest-
ing applications. For instance, destroying microbubbles within
the ultrasound beam and measuring their reappearance rate
might allow quantification of the mean myocardial micro-
bubble velocity during continuous venous infusions (26). Sim-
ilarly, using a long pulsing interval to allow microbubble
saturation of the beam could permit assessment of relative
myocardial blood volume (26). Drugs and genetic material
could be delivered to tissue by way of microbubbles that could
then be destroyed with ultrasound at the required site, provid-
ing a means of efficient local delivery.
Conclusions. Ultrasound results in microbubble destruc-
tion that is more evident at lower frequencies and higher
acoustic powers. Reducing the exposure of microbubbles to
ultrasound minimizes their destruction. This effect is greater
with harmonic than with fundamental imaging with the ultra-
sound system we used. It is also more pronounced in vivo when
microbubbles are injected intravenously than with aortic or
direct coronary artery injections. These findings could lead to
effective strategies for myocardial perfusion imaging and quan-
tification of myocardial blood flow with venous injections of
microbubbles. They could also lead to use of microbubbles for
local tissue delivery of drugs and other material.
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